Last reviewed · How we verify
CeraVe Moisturizing Cream
CeraVe Moisturizing Cream is a Small molecule drug developed by University of Miami. It is currently FDA-approved for Dry skin, Eczema (atopic dermatitis), Sensitive skin.
CeraVe Moisturizing Cream hydrates and protects the skin barrier using ceramides, hyaluronic acid, and petrolatum.
CeraVe Moisturizing Cream hydrates and protects the skin barrier using ceramides, hyaluronic acid, and petrolatum. Used for Dry skin, Eczema (atopic dermatitis), Sensitive skin.
At a glance
| Generic name | CeraVe Moisturizing Cream |
|---|---|
| Sponsor | University of Miami |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
The cream contains three essential ceramides (1, 3, and 6-II) that restore the skin's lipid barrier, hyaluronic acid that draws moisture into the stratum corneum, and petrolatum that provides occlusive protection. This combination helps repair compromised skin barriers and maintain hydration in dry or sensitive skin conditions.
Approved indications
- Dry skin
- Eczema (atopic dermatitis)
- Sensitive skin
- General skin moisturization and barrier repair
Common side effects
- Local irritation or rash
- Allergic contact dermatitis
Key clinical trials
- Skin Barrier Function and Inflammation in Aging: The BIA Study (PHASE4)
- Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application). (NA)
- CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis (NA)
- A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen (NA)
- Efficacy of CeraVe® Moisturizing Cream on Skin Pruritus in Elderly Patients (NA)
- CeraVe Diabetes Mellitus (PHASE4)
- The Effects of Emollient Therapy on the Skin Barrier (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CeraVe Moisturizing Cream CI brief — competitive landscape report
- CeraVe Moisturizing Cream updates RSS · CI watch RSS
- University of Miami portfolio CI
Frequently asked questions about CeraVe Moisturizing Cream
What is CeraVe Moisturizing Cream?
How does CeraVe Moisturizing Cream work?
What is CeraVe Moisturizing Cream used for?
Who makes CeraVe Moisturizing Cream?
What development phase is CeraVe Moisturizing Cream in?
What are the side effects of CeraVe Moisturizing Cream?
Related
- Manufacturer: University of Miami — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Dry skin
- Indication: Drugs for Eczema (atopic dermatitis)
- Indication: Drugs for Sensitive skin
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing